ClinicalTrials.gg
Not yet recruitingNCT06833346Updated Mar 7, 2025

Efficacy of Hip Belt Squat Training on Pain Management and Physcial Function in Low Back Pain Patients

An interventional study of Hip belt squat exercise in Low Back Pain, sponsored by Aalborg University. Not yet recruiting at 1 site in Denmark. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-03-07.

Sponsored by Aalborg University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 56 studies in Low Back Pain with a site in Denmark — 5 open to participants now, 6 under way, none of them phase 3. Low Back Pain · Denmark.

Planned enrollment
29th of 38
60 · median 125
Started
2025
with 1 other
No phase
32 of 56
2 open now
Registered
54th of 56
by date
Lead sponsor
7 of 56
Aalborg University

Among the 56 studies in Low Back Pain with a site in Denmark, this one is the 29th largest by planned enrollment of the 38 interventional ones that give a count, is one of 2 that started in 2025, is one of 32 with no phase, and was the 54th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

5 of the 56 studies in Low Back Pain with a site in Denmark are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 56 studies in Low Back Pain with a site in Denmark, or all of them as a file.
02

Study summary

The purpose of this project is to investigate the efficacy of the hip belt squat exercise in pain management and physical function for people with chronic low back pain.

Read the detailed description

This study is a randomized controlled trial (RCT) designed to evaluate the effectiveness of a 12-week hip belt squat (HBS) intervention for patients with non-specific low back pain (LBP). Participants, aged 18-60 with LBP for more than 12 weeks, are randomly assigned to either the intervention group or a control group. The control group will not receive any intervention, whereas the HBS intervention consists of two supervised sessions per week for 12 weeks, with load adjustments based on perceived exertion.

The study aims to recruit 50-60 patients to ensure sufficient statistical power. Primary outcomes include health-related quality of life (EQ-5D-5L), fear-avoidance beliefs (FABQ), functional ability (ODI), risk of chronicity (STarTBack), pain intensity (VAS), and pain sensitivity (PPT). Secondary outcomes include body composition (DEXA), lumbar flexibility, maximal muscle strength (5RM), physical activity (GPAQ), tobacco use (SQ), and work-related stress (WSQ).

Measurements are taken at baseline, 6 weeks, 12 weeks, and a 1-year follow-up for various outcomes. This comprehensive approach aims to provide valuable insights into the effectiveness of the HBS intervention for managing LBP.

03

Conditions studied

  • Low Back Pain

Browse trials for

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Men and women with non-specific low back pain for more than twelve weeks, with a VAS score of at least 3, taken as an average of the last week, and ODI>20

Exclusion criteria

Exclusion Criteria:

  • Leg pain greater than back pain
  • Neuromuscular disorders
  • Spinal or lower extremity fractures
  • Infections
  • Cancer
  • Osteoporosis
  • Dementia
  • Current substance abuse
  • Former lumbar surgery
  • Persistent pain syndromes other than back pain
  • Inflammatory rheumatic diseases
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • No intervention
    Control

    Low back pain patients not performing an intervention

  • Experimental
    Hip belt squat exercise

    Low back pain patients performing hip belt squat training twice per week for 12 weeks.

    Other: Hip belt squat exercise

Interventions

  • OtherHip belt squat exercise

    Hip belt squat exercise performed twice per week for 12 weeks

06

What researchers measure

Primary outcomes

  1. Oswetry Disability index

    A questionnaire measuring the degree of disability, which ranges from 0 (no disability) to 100 (bedridden).

    Time frame: Assessed at baseline, after 6 weeks, 12 weeks, and at 1-year followup

  2. Health related quality of life

    A questionnaire measuring the easured health-related quality of life (EuroQOL-5D), ranging from -0.596 to 1, with higher scores indicating better quality of life.

    Time frame: Assessed at baseline, after 6 weeks, 12 weeks, and at 1-year followup

  3. Fear-avoidance Beliefs Questionnaire

    Fear-avoidance Beliefs Questionnaire (FABQ) measuring the amount of kinesiophobia, ranging from 0-96 with higher scores indicating higher levels of fear avoidance belief.

    Time frame: Assessed at baseline, after 6 weeks, 12 weeks, and at 1-year followup

  4. STarTBack tool

    A questionnaire used to assess the risk of chronicity in low back pain (ranging from low to medium to high risk).

    Time frame: Assessed at baseline, after 6 weeks, 12 weeks, and at 1-year followup

  5. Pain sensitivity

    Pressure-pain threshold was assessed using a handheld pressure algometer.

    Time frame: Assessed at baseline, after 6 weeks, 12 weeks, and at 1-year followup

  6. Pain intensity

    Patients were asked to rate the intensity of their LBP on a visual analog scale (VAS) using a 10 cm long line, where the far-left part of the line (0/10) corresponded to no pain and the far right part (10/10) corresponded to the worst imaginable pain. Ratings on the VAS scale was gathered both while the participants stood in an upright position and during a self-chosen movement known to induce pain (e.g. bending over).

    Time frame: Assessed at baseline, after 6 weeks, 12 weeks, and at 1-year followup

Secondary outcomes

  1. Muscle strength

    Muscle strength was assessed in the hop belt squat exercise using a 5 repetition maximum test

    Time frame: Assessed at baseline, after 6 weeks, 12 weeks, and at 1-year followup

  2. Lumbar flexibility

    Lumbar flexibility was assessed using a custom made test.

    Time frame: Assessed at baseline, after 6 weeks, 12 weeks, and at 1-year followup

  3. Body composition

    To assess changes in body composition a DEXA scan was performed. This test quantified lean body mass (kg) and fat mass (kg).

    Time frame: Assessed at baseline, after 6 weeks, 12 weeks, and at 1-year followup

  4. Physical activity level

    To assess the physical activity level of the patients the Global Physical Activity Questionnaire (GPAQ) questionnaire was used. Higher scores indicate higher levels of physical activity, which is considered better for health. Lower scores indicate lower levels of physical activity, which is considered worse for health. Interpretation: High Physical Activity: More than 3000 MET-minutes per week. Moderate Physical Activity: Between 600 and 3000 MET-minutes per week. Low Physical Activity: Less than 600 MET-minutes per week.

    Time frame: Assessed at baseline, after 6 weeks, 12 weeks, and at 1-year followup

  5. Tobacco use

    To assess tobacco use, patients were questioned using the Smoking Questionnaire (SQ).

    Time frame: Assessed at baseline, after 6 weeks, 12 weeks, and at 1-year followup

  6. Work related stress

    To assess work related stress, the Work Stress Questionnaire (WSQ) was used. Lower scores indicate lower levels of work-related stress, which is considered better for overall well-being. Higher scores indicate higher levels of work-related stress, which can negatively impact health and job performance. Interpretation: Scores below 135: Indicate a normal level of work-related stress. Scores of 135 or above: Suggest an unusual amount of work-related stress, indicating the need for stress management interventions.

    Time frame: Assessed at baseline, after 6 weeks, 12 weeks, and at 1-year followup

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Individual participant data is protected under GDPR

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2025; primary completion for Jun 2026, 15 months later.

Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 15 months is above that.

Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 13, 2025
First posted
Feb 18, 2025
StartEst.
Mar 1, 2025
Primary completionEst.
Jun 1, 2026
CompletionEst.
Aug 2026
Last update
Mar 7, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 7, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06833346
Lead sponsor
Aalborg University
Collaborators
Aleris
Responsible party
Mathias Kristiansen (Associate Professor, Aalborg University) — Principal investigator
First posted
Feb 18, 2025
Start date
Mar 1, 2025 (estimated)
Primary completion
Jun 1, 2026 (estimated)
Completion
Aug 2026 (estimated)
Last update
Mar 7, 2025

Study contacts

Mathias Kristiansen, PhD
Contact
mvk@hst.aau.dk
+4526803461

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion